Vital Pulp Therapy Versus Root Canal for Irreversible Pulpitis Using AI, Apr 24
Summary
NIH registered clinical trial NCT07549620 comparing vital pulp therapy against standard root canal treatment for patients with symptomatic irreversible pulpitis and incipient apical periodontitis. The study will measure postoperative pain intensity as the primary outcome, with secondary outcomes including long-term clinical and radiographic success at 6 months and 1 year using AI-assisted analysis for evaluation. This trial is listed as 'This Keeps' status with an April 24, 2026 posting date.
“This study evaluates postoperative pain and treatment outcomes following vital pulp therapy and root canal treatment in patients with symptomatic teeth.”
About this source
ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.
What changed
NIH registered clinical trial NCT07549620 as a new study entry on ClinicalTrials.gov. The trial will enroll patients with symptomatic irreversible pulpitis and compare two treatment approaches: vital pulp therapy versus standard root canal treatment. Participants will be assessed for postoperative pain intensity as the primary outcome, with secondary endpoints including 6-month and 1-year clinical and radiographic success rates. The study employs artificial intelligence-assisted analysis for radiographic outcome evaluation.
Healthcare providers and dental researchers should note this trial as a registered comparative effectiveness study in endodontic treatment. The trial's use of AI-assisted analysis for outcome assessment may be relevant for those tracking AI applications in dental diagnostics. No compliance obligations are created by this registry entry.
Archived snapshot
Apr 25, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Vital Pulp Therapy Versus Root Canal Treatment for Irreversible Pulpitis With Incipient Apical Periodontitis Diagnosed Using Artificial Intelligence This Keeps: the Main Intervention (Vital Pulp Therapy) the Comparison (Root Canal Treatment) the Condition (Irreversible Pulpitis With Incipient Apic
N/A NCT07549620 Kind: NA Apr 24, 2026
Abstract
This study evaluates postoperative pain and treatment outcomes following vital pulp therapy and root canal treatment in patients with symptomatic teeth. Participants will receive either vital pulp therapy or standard root canal treatment, and pain will be measured using standardized pain scores at different time intervals after treatment.
The primary outcome is postoperative pain intensity in the early healing period. Secondary outcomes include long-term clinical and radiographic success at 6 months and 1 year.
Radiographic outcomes will be assessed using artificial intelligence (AI)-assisted analysis to improve evaluation of healing and treatment success.
The study aims to compare pain progression and long-term outcomes between the two treatment approaches.
Conditions: Symptomatic Irreversible Pulpitis
Interventions: Vital Pulp Therapy, Root Canal Treatment
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.